Subscribe to RSS
Calcaneal fracturesOutcome and complications following the use of calcium phosphate bone cement
28 November 2006 (online)
Evidence from four small case series, class of evidence (CoE) IV, regarding the safety and efficacy of calcium phosphate bone cement in the treatment of calcaneal fractures is weak. Wound infections occurred in 7% of cases across three of the series (5 out of 70 cases) that used Norian SRS, but were not thought to be related to the presence of bone cement. One suspected infection (of 11 cases) was noted using the Biobon cement. Acceptable reduction and joint reconstruction were experienced in all three series of patients treated with Norian SRS. In the two studies that used scoring systems, poor to good clinical outcomes were reported.
Given that this report consists only of three modest-sized case series, well designed comparative studies are needed to clarify whether augmentation with calcium phosphate bone cement for the treatment of calcaneal fractures safely improves outcomes.